PVR and neoplasm: The activation of NK cells by DCs (e.g., IL-12, CD226/CD155) may act as a feed-forward loop to increase DC activation through the induction of NK cell production of chemokines and cytokines, subsequently improving anti-tumor immune responses [rev.